BioCentury
ARTICLE | Clinical News

Integra LifeSciences Corp regulatory update

January 8, 1996 8:00 AM UTC

IART received an approvable letter from the FDA for its PMA to market Integra Artificial Skin, Dermal Regeneration Template, a treatment for patients with life-threatening full-thickness or deep partial-thickness burns where conventional autograft is not available or not desirable. ...